Author:
Schneider Michael,Nasta Sunita D.,Barta Stefan K.,Chong Elise A.,Svoboda Jakub,Schuster Stephen J.,Landsburg Daniel J.
Funder
Lymphoma Research Foundation of America
Reference34 articles.
1. Diffuse large B-cell lymphoma;Sehn;New England Journal of Medicine,2021
2. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study;Crump;Blood, The Journal of the American Society of Hematology.,2017
3. Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY. 12;Crump;Journal of Clinical Oncology,2014
4. Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era;Gisselbrecht;Journal of Clinical Oncology,2010
5. Axicabtagene ciloleucel as second-line therapy for large B-cell lymphoma;Locke;New England Journal of Medicine,2022